4-oxo-2-nonenal has been researched along with alpha-synuclein in 8 studies
Studies (4-oxo-2-nonenal) | Trials (4-oxo-2-nonenal) | Recent Studies (post-2010) (4-oxo-2-nonenal) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
---|---|---|---|---|---|
94 | 0 | 47 | 10,821 | 29 | 8,011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bergström, J; Ingelsson, M; Karlsson, M; Lannfelt, L; Näsström, T; Nikolajeff, F; Wahlberg, T | 1 |
Barbu, M; Bergström, J; Ekberg, M; Fagerqvist, T; Ingelsson, M; Karlsson, M; Kasrayan, A; Lannfelt, L; Näsström, T; Nikolajeff, F | 1 |
Bergström, J; Fagerqvist, T; Ihse, E; Ingelsson, M; Kahle, PJ; Karlsson, M; Kasaryan, A; Lannfelt, L; Lindström, V; Näsström, T; Nikolajeff, F; Outeiro, TF; Sahlin, C; Schell, H; Tucker, SM | 1 |
Bergström, J; Cai, Y; Ingelsson, M; Karlsson, M; Kasrayan, A; Lannfelt, L; Lendel, C; Nikolajeff, F; Österlund, L | 1 |
Almandoz-Gil, L; Bergström, J; Ihse, E; Ingelsson, M; Karlsson, M; Khoonsari, PE; Kultima, K; Lendel, C; Musunuri, S; Sigvardson, J; Welander, H | 1 |
Almandoz-Gil, L; Bergström, J; Ingelsson, M | 1 |
Andersen, C; Christiansen, G; Grønnemose, AL; Jørgensen, TJD; Mulder, FAA; Nielsen, J; Nowak, JS; Otzen, DE; Pedersen, JN | 1 |
Andersen, CB; Arnspang, EC; Clausen, MP; Lausdahl, AK; Mulder, FAA; Nielsen, J; Otzen, DE | 1 |
8 other study(ies) available for 4-oxo-2-nonenal and alpha-synuclein
Article | Year |
---|---|
The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers.
Topics: Aldehydes; alpha-Synuclein; Amyloid; Chromatography, High Pressure Liquid; Humans; Lipid Peroxidation; Microscopy, Atomic Force; Molecular Weight; Parkinsonian Disorders; Protein Conformation; Sodium Dodecyl Sulfate | 2009 |
The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties.
Topics: Aldehydes; alpha-Synuclein; Cell Survival; Humans; Inclusion Bodies; Lipid Peroxidation; Protein Multimerization; Protein Stability; Protein Structure, Secondary; Tumor Cells, Cultured | 2011 |
Off-pathway α-synuclein oligomers seem to alter α-synuclein turnover in a cell model but lack seeding capability in vivo.
Topics: Aldehydes; alpha-Synuclein; Animals; Brain; Cell Line, Tumor; Humans; Mice; Mice, Transgenic; Microscopy, Atomic Force; Parkinson Disease | 2013 |
Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes.
Topics: Aldehydes; alpha-Synuclein; Chromatography, Gel; Circular Dichroism; Humans; Kinetics; Molecular Weight; Oxidation-Reduction; Protein Multimerization; Protein Structure, Secondary; Recombinant Proteins | 2015 |
Low molar excess of 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote oligomerization of alpha-synuclein through different pathways.
Topics: Aldehydes; alpha-Synuclein; Amino Acid Sequence; Endopeptidase K; Humans; Hydrogen-Ion Concentration; Lipid Peroxidation; Oxidative Stress; Peptide Fragments; Protein Multimerization; Proteolysis; Solutions | 2017 |
Generation and Characterization of Stable α-Synuclein Oligomers.
Topics: Aldehydes; alpha-Synuclein; Electrophoresis, Polyacrylamide Gel; Humans; Microscopy, Atomic Force; Parkinson Disease; Protein Multimerization; Protein Stability | 2018 |
Lipid Peroxidation Products HNE and ONE Promote and Stabilize Alpha-Synuclein Oligomers by Chemical Modifications.
Topics: Aldehydes; alpha-Synuclein; Cell Line, Tumor; Humans; Lipid Peroxidation; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Protein Aggregates; Recombinant Proteins; Scattering, Small Angle; X-Ray Diffraction | 2021 |
4-Oxo-2-nonenal-Induced α-Synuclein Oligomers Interact with Membranes in the Cell, Leading to Mitochondrial Fragmentation.
Topics: Aldehydes; alpha-Synuclein; Humans; Lipid Peroxidation; Parkinson Disease | 2023 |